Primary thyroid squamous cell carcinoma is extremely rare. We report a case of primary thyroid squamous cell carcinoma diagnosed using F-FDG PET/CT. The patient presented with left axillary lymphadenopathy as the initial symptom.
View Article and Find Full Text PDFObjective: To conduct a meta-analysis of the efficacy and safety of Ac-PSMA-617 in the treatment of metastatic castration-resistant prostate cancer based on existing clinical evidence.
Methods: Search for retrospective studies about Ac-PSMA-617 in the treatment of metastatic castration-resistant prostate cancer from establishment to July 2021 in PubMed and EMBASE. The primary endpoint was Ac-PSMA-617 biochemical response evaluation criteria after treatment [any prostate specific antigen (PSA) decrease and PSA decrease >50% from baseline] to evaluate the treatment effect.
Purpose: The present retrospective analysis sought to compare the relative diagnostic efficacy of [Ga]Ga-DOTA-FAPI-04 to that of [F]FDG PET/CT as a means of detecting bone metastases in patients with a range of cancer types.
Materials: In total, 30 patients with bone metastases associated with different underlying malignancies were retrospectively enrolled. All patients had undergone [Ga]Ga-DOTA-FAPI-04 and [F]FDG PET/CT, and the McNemar test was used to compare the relative diagnostic performance of these two imaging modalities.
Subcutaneous Ewing sarcoma is very rare. This report presents the case of a 23-year-old woman with a history of primary subcutaneous Ewing sarcoma who recently found a gradually increasing mass. Recurrent subcutaneous Ewing sarcoma was thus suspected.
View Article and Find Full Text PDF